Liraglutide 3.0 Mg Improves Body Weight and Cardiometabolic Risk Factors in Overweight or Obese Adults without Diabetes: The Scale Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled 56-Week Trial

被引：0
|
作者：
Le Roux, Carel [1 ]
Astrup, Arne [2 ]
Fujioka, Ken [3 ]
Greenway, Frank Lyons [4 ]
Halpern, Alfredo [5 ]
Krempf, Michel [6 ]
Lau, David C. [7 ]
Ortiz, Rafael Violante [8 ]
Wilding, John [9 ]
Jensen, Christine Bjorn [10 ]
Pi-Sunyer, F. Xavier [11 ]
机构：
[1] Univ Coll Dublin, Dublin, Ireland
[2] Univ Copenhagen, Frederiksberg C, Denmark
[3] Scripps Clin, La Jolla, CA 92037 USA
[4] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[5] Univ Sao Paulo, Sao Paulo, Brazil
[6] Hop Nord Laennec, Nantes, France
[7] Univ Calgary, Calgary, AB, Canada
[8] Inst Mexicano Seguro Social, Cuidad Madero, Tamaulipas, Mexico
[9] Univ Liverpool, Liverpool, Merseyside, England
[10] Novo Nordisk AS, Soborg, Norway
[11] St Lukes Roosevelt Hosp, New York, NY 10025 USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0937
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A Natural Fiber Complex Reduces Body Weight in the Overweight and Obese: A Double-Blind, Randomized, Placebo-Controlled Study
    Grube, Barbara
    Chong, Pee-Win
    Lau, Kai-Zhia
    Orzechowski, Hans-Dieter
    OBESITY, 2013, 21 (01) : 58 - 64
  • [22] Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
    Ellen M. Apperloo
    Jose L. Gorriz
    Maria Jose Soler
    Secundino Cigarrán Guldris
    Josep M. Cruzado
    Maria Jesús Puchades
    Marina López-Martínez
    Femke Waanders
    Gozewijn D. Laverman
    Annemarie van der Aart-van der Beek
    Klaas Hoogenberg
    André P. van Beek
    Jacobien Verhave
    Sofia B. Ahmed
    Roland E. Schmieder
    Christoph Wanner
    David Z. I. Cherney
    Niels Jongs
    Hiddo J. L. Heerspink
    Nature Medicine, 2025, 31 (1) : 278 - 285
  • [23] Effect of oligofructose supplementation on body weight in overweight and obese children: a randomised, double-blind, placebo-controlled trial
    Liber, Anna
    Szajewska, Hania
    BRITISH JOURNAL OF NUTRITION, 2014, 112 (12) : 2068 - 2074
  • [24] Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial
    Menon, Kirthi
    Cameron, James D.
    de Courten, Maximilian
    de Courten, Barbora
    BMJ OPEN, 2021, 11 (05):
  • [25] Effect of Liraglutide on Cardiovascular (CV) Risk Factors in Adults Without Diabetes After Diet-Induced Weight Loss: The SCALE™ 56-Week Randomized Study
    Klein, Samuel
    Aronne, Louis J.
    Hollander, Priscilla
    Niswender, Kevin
    Woo, Vincent
    Hale, Paula M.
    Rasmussen, Mads F.
    Wadden, Thomas A.
    OBESITY, 2011, 19 : S177 - S177
  • [26] Effects of oral -lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double-blind, placebo-controlled trial
    Li, Nong
    Yan, Weili
    Hu, Xiaojuan
    Huang, Yongdi
    Wang, Fugang
    Zhang, Weiguo
    Wang, Qian
    Wang, Xiaoling
    Sun, Kehong
    CLINICAL ENDOCRINOLOGY, 2017, 86 (05) : 680 - 687
  • [27] Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
    Neeland, Ian J.
    Marso, Steven P.
    Ayers, Colby R.
    Lewis, Bienka
    Oslica, Robert
    Francis, Wynona
    Rodder, Susan
    Pandey, Ambarish
    Joshi, Parag H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (09): : 595 - 605
  • [28] Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial
    Danielsson, Pernilla
    Putri, Resthie R.
    Marcus, Claude
    Hagman, Emilia
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial
    Pernilla Danielsson
    Resthie R. Putri
    Claude Marcus
    Emilia Hagman
    Scientific Reports, 13
  • [30] Characteristics of Individuals Developing Type 2 Diabetes in the SCALE Obesity and Prediabetes Randomized, Double-Blind, Liraglutide vs. Placebo Trial
    Lau, David C. W.
    Blueher, Matthias
    Van Gaal, Luc
    Rubino, Domenica M.
    Guerrero, German
    Manning, Linda Shapiro
    Wilding, John P. H.
    DIABETES, 2016, 65 : A510 - A510
12345